Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb randomized double-blind placebo-controlled study of BJY-802 in stable angina pectoris
ChiCTR2000034858Phase 2Recruiting
- Sponsor
- Xiyuan Hospital
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BJY-802 in stable angina and coronary arteriosclerosis (3 arms), sponsored by Xiyuan Hospital. Primary endpoint: Percentage of patients with 0 angina attacks. Started Jul 2020; status: recruiting.
02
Drugs
BJY-802
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2000034858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034858.